The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study
Abstract
OBJECTIVES : To examine the rate and predictors of nursing home placement in patients with Parkinson's disease. DESIGN : Four‐year prospective study. SETTING : A population‐based study in western Norway PARTICIPANTS : 178 community‐dwelling subjects with Parkinson's disease. MEASUREMENTS : Main outcome measure was the time from baseline to nursing home admission. Baseline evaluation of motor symptoms (Unified Parkinson's Disease Rating Scale, UPDRS), cognition (clinical dementia interview, Gottfries, Bråne & Steen dementia scale, and Mini‐Mental State Examination), depression (clinical interview and the Montgomery & Åsberg Depression Rating Scale), and psychotic symptoms (UPDRS Thought Disorder item) were performed. RESULTS : Forty‐seven patients (26.4%) were admitted to a nursing home during the 4‐year study period. Institutionalized patients were older, had more advanced Parkinson's disease with more severe motor symptoms and impairment of activities of daily living, were cognitively more impaired, were more often living alone, and had more hallucinations than those who continued to live at home. Duration of disease, levodopa dose, and gender distribution did not differ between the two groups. A Cox proportional hazards linear regression analysis showed that old age, functional impairment, dementia, and hallucinations were independent predictors of nursing home admission. CONCLUSIONS : Both motor and neuropsychiatric symptoms contributed to institutionalization, but the presence of hallucinations was the strongest predictor. This finding indicates it is possible that effective treatment of hallucinations may reduce the need for institutionalization in patients with Parkinson's disease. J Am Geriatr Soc 48:938–942, 2000 .
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Parkinson disease (PD) is progressive, with dementia and medication-refractory motor problems common reasons for late-stage nursing-home placement.”
From Does vigorous exercise have a neuroprotective effect in Parkinson disease? (2011) · cites this paper as [1]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Parkinsonism: onset, progression, and mortality
Hoehn, M. M., & Yahr, M. D. (1967) · Neurology · doi:10.1212/wnl.17.5.427 · Cited by 12,107
Low-Dose Clozapine for the Treatment of Drug-Induced Psychosis in Parkinson's Disease
The Parkinson Study Group (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401003 · Cited by 618
Mental symptoms in Parkinson's disease are important contributors to caregiver distress
Aarsland, D., Larsen, J. P., Karlsen, K., Lim, N. G., & Tandberg, E. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199910)14:10 · Cited by 484
Self-citationRisk factors for nursing home placement in advanced Parkinson's disease
Goetz, C. G., & Stebbins, G. T. (1993) · Neurology · doi:10.1212/wnl.43.11.2227 · Cited by 460
A prospective study of long-term care institutionalization among the aged.
Branch, L. G., & Jette, A. M. (1982) · American Journal of Public Health · doi:10.2105/ajph.72.12.1373 · Cited by 440
The Occurrence of Depression in Parkinson's Disease
Tandberg, E. (1996) · Archives of Neurology · doi:10.1001/archneur.1996.00550020087019 · Cited by 413
Self-citationPredictors of Institutionalization Among Caregivers of Patients With Alzheimer's Disease
Colerick, E. J., & George, L. K. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04239.x · Cited by 393
Prevalence and Clinical Correlates of Psychotic Symptoms in Parkinson Disease
Aarsland, D., Larsen, J. P., Cummings, J. L., & Laake, K. (1999) · Archives of Neurology · doi:10.1001/archneur.56.5.595 · Cited by 347
Self-citation
Research works printed but not linked: 2
- Fahn S, 1987, Recent Development in Parkinson's Disease, 153
- 1987, Diagnostic and Statistical Manual of Mental Disorders
Cited by
Sorted by citations
Items 201–300 of 807
Bejr‐Kasem, H., Sampedro, F., Marín‐Lahoz, J., Martínez‐Horta, S., Pagonabarraga, J., & Kulisevsky, J. (2020) · European Journal of Neurology · doi:10.1111/ene.14576 · Cited by 55
Lewy body dementia and Parkinson’s disease with dementia
Dodel, R. C., Csóti, I., Ebersbach, G., Fuchs, G., Hahne, M., Kuhn, W., Oechsner, M., Jost, W. H., Reichmann, H., & Schulz, J. B. (2008) · Journal of Neurology · doi:10.1007/s00415-008-5007-0 · Cited by 55
Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK)
Balzer‐Geldsetzer, M., Costa, A. S., Kronenbürger, M., Schulz, J. B., Röske, S., Spottke, A. E., Wüllner, U., Klockgether, T., Storch, A., Schneider, C. B., et al. (2011) · Neuroepidemiology · doi:10.1159/000331490 · Cited by 55
Long‐term outcome of clozapine use for psychosis in parkinsonian patients
Fernandez, H. H., Donnelly, E. M., & Friedman, J. H. (2004) · Movement Disorders · doi:10.1002/mds.20051 · Cited by 47
Oehlberg, K., Barg, F. K., Brown, G. K., Taraborelli, D., Stern, M. B., & Weintraub, D. (2008) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988708316862 · Cited by 53
Hallucinations and psychosis in Parkinson's disease
Rabey, J. M. (2009) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(09)70846-6 · Cited by 53
Cognitive Impairment in Parkinson’s Disease and Dementia with Lewy Bodies: A Spectrum of Disease
Gross, R. G., Siderowf, A. D., & Hurtig, H. I. (2007) · Neurosignals · doi:10.1159/000109756 · Cited by 53
Loss of Functional Connectivity in Patients with Parkinson Disease and Visual Hallucinations
Hepp, D. H., Foncke, E. M. J., Dubbelink, K. T. E. O., van de Berg, W. D. J., Berendse, H. W., & Schoonheim, M. M. (2017) · Radiology · doi:10.1148/radiol.2017170438 · Cited by 53
ACTUALIZACIÓN EN LA ENFERMEDAD DE PARKINSON
Martínez‐Fernández, R., Gasca‐Salas, C., Sánchez‐Ferro, Á., & Obeso, J. A. (2016) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2016.06.010 · Cited by 52
Step length predicts executive dysfunction in Parkinson’s disease: a 3-year prospective study
Amboni, M., Iuppariello, L., Iavarone, A., Fasano, A. A., Palladino, R., Rucco, R., Picillo, M., Lista, I., Varriale, P., Vitale, C., et al. (2018) · Journal of Neurology · doi:10.1007/s00415-018-8973-x · Cited by 52
Non-Motor Aspects of Parkinson's Disease
Borek, L. L., Amick, M. M., & Friedman, J. H. (2006) · CNS Spectrums · doi:10.1017/s1092852900013560 · Cited by 53
Association between antidepressants and falls in Parkinson’s disease
Martínez-Ramírez, D., Giugni, J. C., Almeida, L., Walz, R., Ahmed, B., Chai, F. A., Rundle-Gonzalez, V., Bona, A. R., Hastings, E., Shukla, A. W., et al. (2015) · Journal of Neurology · doi:10.1007/s00415-015-7947-5 · Cited by 51
Divac, N., Stojanović, R., Vujović, K. S., Medić, B., Damjanović, A., & Prostran, M. S. (2016) · Behavioural Neurology · doi:10.1155/2016/4938154 · Cited by 53
Dujardin, K., & Sgambato, V. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00025 · Cited by 46
Hippocampal atrophy predicts conversion to dementia after STN-DBS in Parkinson's disease
Aybek, S., Lazeyras, F., Gronchi‐Perrin, A., Burkhard, P. R., Villemure, J., & Vingerhoets, F. J. G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.01.003 · Cited by 50
Wood, K. H., Memon, A. A., Memon, R. A., Joop, A., Pilkington, J., Catiul, C., Gerstenecker, A., Triebel, K., Cutter, G., Bamman, M. M., et al. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202215 · Cited by 55
Loss of independence in early Parkinson disease
Bjørnestad, A. L., Tysnes, O., Larsen, J. P., & Alves, G. W. (2016) · Neurology · doi:10.1212/wnl.0000000000003213 · Cited by 50
Self-citationTerminology and assessment tools of psychosis: A systematic narrative review
Seiler, N., Nguyen, T., Yung, A. R., & O'Donoghue, B. N. (2019) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12966 · Cited by 53
McLennon, S. M., Habermann, B., & Davis, L. L. (2010) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0b013e3181ce5c45 · Cited by 50
How well do we recognise non-motor symptoms in a British Parkinson’s disease population?
Hu, M., Cooper, J., Beamish, R., Jones, E., Butterworth, R. J., Catterall, L., & Ben‐Shlomo, Y. (2011) · Journal of Neurology · doi:10.1007/s00415-011-5972-6 · Cited by 49
Neuropsychiatry of Parkinson's disease
Kümmer, A., & Teixeira, A. L. (2009) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2009000500033 · Cited by 49
Movement Disorders Emergencies Part 2
Robottom, B., Factor, S. A., & Weiner, W. J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.117 · Cited by 49
Deciding to institutionalize: why do family members cease caregiving at home?
McLennon, S. M., Habermann, B., & Davis, L. L. (2010) · PubMed · Cited by 48
Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson’s Disease Dementia
Oh, Y., Kim, J., & Lee, P. H. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15041 · Cited by 47
Oh, Y., Lee, J. E., Lee, P. H., & Kim, J. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.14019 · Cited by 47
Hand, A., Oates, L. L., Gray, W. K., & Walker, R. W. (2018) · Aging & Mental Health · doi:10.1080/13607863.2017.1421612 · Cited by 46
Identifying the neural correlates of doorway freezing in Parkinson's disease
Matar, E., Shine, J. M., Gilat, M., Martens, K. A. E., Ward, P. B., Frank, M. J., Moustafa, A. A., Naismith, S. L., & Lewis, S. J. G. (2019) · Human Brain Mapping · doi:10.1002/hbm.24506 · Cited by 47
Low, A., Foo, H., Yong, T. T., Tan, L. C. S., & Kandiah, N. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2018-319592 · Cited by 48
Bolitho, S., Naismith, S. L., Terpening, Z., Grunstein, R. R., Melehan, K. L., Yee, B. J., Coeytaux, A., Gilat, M., & Lewis, S. J. G. (2014) · Movement Disorders · doi:10.1002/mds.25832 · Cited by 46
A novel paradigm for modelling freezing of gait in Parkinson’s disease
Naismith, S. L., & Lewis, S. J. G. (2010) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2009.12.006 · Cited by 46
Pimavanserin: novel pharmacotherapy for Parkinson’s disease psychosis
Sahli, Z. T., & Tarazi, F. I. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1394838 · Cited by 46
Miller, E. A., & Rosenheck, R. A. (2006) · Medical Care · doi:10.1097/01.mlr.0000204008.83633.ed · Cited by 47
Non-motor Symptoms Questionnaire und Scale für das idiopathische Parkinson-Syndrom
Storch, A., Odin, P., Trender‐Gerhard, I., Fuchs, G., Reifschneider, G., Chaudhuri, К. R., Jost, W. H., & Ebersbach, G. (2010) · Der Nervenarzt · doi:10.1007/s00115-010-3010-z · Cited by 45
New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease
Goetz, C. G. (2010) · Movement Disorders · doi:10.1002/mds.22636 · Cited by 45
Bolitho, S., Naismith, S. L., Salahuddin, P., Terpening, Z., Grunstein, R. R., & Lewis, S. J. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081233 · Cited by 45
Risk of sleep-disordered breathing in Parkinson's disease
Chotinaiwattarakul, W., Dayalu, P., Chervin, R. D., & Albin, R. L. (2010) · Sleep And Breathing · doi:10.1007/s11325-010-0362-3 · Cited by 45
Psychosis in Parkinson's Disease
Ffytche, D. H., & Aarsland, D. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.04.005 · Cited by 45
Self-citationThe Prevalence and Determinants of Neuropsychiatric Symptoms in Late‐Stage Parkinsonism
Hommel, A., Meinders, M., Lorenzl, S., Dodel, R., Coelho, M., Ferreira, J., Laurens, B., Spampinato, U., Meissner, W., Rosqvist, K., et al. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12968 · Cited by 36
The effect of quetiapine in psychotic Parkinsonian patients with and without dementia
Prokhorov, T., Klein, C., Miniovitz, A., Dobronevsky, E., & Rabey, J. M. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0943-4 · Cited by 45
Parkinson Disease in Long Term Care Facilities: A Review of the Literature
Weerkamp, N. J., Tissingh, G., Poels, P. J. E., Zuidema, S. U., Munneke, M., Koopmans, R. T. C. M., & Bloem, B. R. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.10.007 · Cited by 49
Dlay, J. K., Duncan, G. W., Khoo, T. K., Williams-Gray, C. H., Breen, D. P., Barker, R. A., Burn, D. J., Lawson, R. A., & Yarnall, A. J. (2020) · Brain Sciences · doi:10.3390/brainsci10020078 · Cited by 44
Perspectives on Parkinson Disease Care in Dutch Nursing Homes
van Rumund, A., Weerkamp, N. J., Tissingh, G., Zuidema, S. U., Koopmans, R. T. C. M., Munneke, M., Poels, P. J. E., & Bloem, B. R. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.05.009 · Cited by 44
Neural correlates of executive functions in healthy G2019S LRRK2 mutation carriers
Thaler, A., Mirelman, A., Helmich, R. C. G., van Nuenen, B. F. L., Rosenberg‐Katz, K., Gurevich, T., Orr‐Urtreger, A., Marder, K. S., Bressman, S., Bloem, B. R., et al. (2013) · Cortex · doi:10.1016/j.cortex.2012.12.017 · Cited by 44
Predicting loss of independence and mortality in frontotemporal lobar degeneration syndromes
Murley, A. G., Rouse, M. A., Coyle-Gilchrist, I. T. S., Jones, P. S., Li, W., Wiggins, J., Lansdall, C. J., Rodríguez, P. V., Wilcox, A., Patterson, K. E., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-324903 · Cited by 46
The Role of Mild Depression in Sleep Disturbance and Quality of Life in Parkinson's Disease
Naismith, S. L., Hickie, I. B., & Lewis, S. J. G. (2010) · Journal of Neuropsychiatry · doi:10.1176/jnp.2010.22.4.384 · Cited by 43
Multidisciplinary Care in Parkinson's Disease
Qamar, M. A., Harington, G., Trump, S., Johnson, J., Roberts, F., & Frost, E. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.02.001 · Cited by 43
Predicting Freezing of Gait in Parkinsons Disease Patients Using Machine Learning
Orphanidou, N. K., Hussain, A. J., Keight, R., Lishoa, P., Hind, J., & Alaskar, H. (2018) · IEEE Congress on Evolutionary Computation (CEC) · doi:10.1109/cec.2018.8477909 · Cited by 43
Greenland, J. C., Cutting, E., Kadyan, S., Bond, S. J., Chhabra, A., & Williams‐Gray, C. H. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-040527 · Cited by 47
Nakas, C. T., Dalrymple‐Alford, J. C., Anderson, T., & Alonzo, T. A. (2012) · Statistics in Medicine · doi:10.1002/sim.5592 · Cited by 42
Habermann, B., & Shin, J. Y. (2016) · Journal of Clinical Nursing · doi:10.1111/jocn.13565 · Cited by 42
Vignando, M., ffytche, D., Lewis, S. J. G., Lee, P. H., Chung, S. J., Weil, R. S., Hu, M. T., Mackay, C. E., Griffanti, L., Pins, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28087-0 · Cited by 42
Characteristics, correlates, and assessment of psychosis in Parkinson disease without dementia
Barrett, M. J., Smolkin, M. E., Flanigan, J. L., Shah, B., Harrison, M. B., & Sperling, S. A. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.011 · Cited by 41
Shine, J. M., Mills, J. M. Z., Qiu, J. X., O’Callaghan, C., Terpening, Z., Halliday, G. M., Naismith, S. L., & Lewis, S. J. G. (2015) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12139 · Cited by 40
Pimavanserin: A Novel Drug Approved to Treat Parkinson's Disease Psychosis.
Kitten, A., Hallowell, S. A., Saklad, S. R., & Evoy, K. E. (2018) · PubMed Central · Cited by 40
Horn, S. R. G.-V., Richardson, H., Xie, S. X., Weintraub, D. A., & Dahodwala, N. A. (2019) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2019.11.009 · Cited by 40
Management of psychiatric disorders in Parkinson's disease
Weintraub, D. A. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00875-w · Cited by 42
Ballard, C. G., Kreitzman, D. L., Isaacson, S., Liu, I.-Y., Norton, J. C., Demos, G., Fernandez, H. H., Ilic, T. V., Azulay, J., Ferreira, J. J., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.06.026 · Cited by 40
Motor Profile and Drug Treatment of Nursing Home Residents with Parkinson's Disease
Weerkamp, N. J., Zuidema, S. U., Tissingh, G., Poels, P. J. E., Munneke, M., Koopmans, R. T. C. M., & Bloem, B. R. (2012) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12027 · Cited by 40
Parkinson's Disease and Sleep/Wake Disturbances
Swick, T. J. (2012) · Parkinson s Disease · doi:10.1155/2012/205471 · Cited by 40
Cumulative exposure to lead and cognition in persons with Parkinson's disease
Weuve, J., Press, D. Z., Grodstein, F., Wright, R. O., Hu, H., & Weisskopf, M. G. (2012) · Movement Disorders · doi:10.1002/mds.25247 · Cited by 39
Testing Visual Perception in Dementia with Lewy Bodies and Alzheimer Disease
Wood, J. S., Firbank, M., Mosimann, U. P., Watson, R., Barber, R., Blamire, A. M., & O'Brien, J. T. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.11.015 · Cited by 39
The role of social support in anxiety and depression among Parkinson’s disease patients
Saeedian, R. G., Nagyová, I., Krokavcova, M., Škorvánek, M., Rosenberger, J., Gdovinová, Z., Groothoff, J. W., & van Dijk, J. P. (2014) · Disability and Rehabilitation · doi:10.3109/09638288.2014.886727 · Cited by 39
Impact of Mood and Behavioral Disorders on Quality of Life in Parkinson’s disease
Rieu, I., Houeto, J. L., Pereira, B., de Chazeron, I., Bichon, A., Chéreau, I., Ulla, M., Brefel‐Courbon, C., Ory‐Magne, F., Dujardin, K., et al. (2016) · Journal of Parkinson s Disease · doi:10.3233/jpd-150747 · Cited by 39
Mild Cognitive Impairment in Parkinson’s Disease: A Review of Current Concepts
Palavra, N. C., Naismith, S. L., & Lewis, S. J. G. (2013) · Neurology Research International · doi:10.1155/2013/576091 · Cited by 39
Thomas, G. E. C., Zeidman, P., Sultana, T., Zarkali, A., Razi, A., & Weil, R. S. (2022) · Brain Communications · doi:10.1093/braincomms/fcac329 · Cited by 38
Eggert, K. M., Öhlwein, C., Kassubek, J., Wolz, M., Kupsch, A. R., Ceballos-Baumann, A., Ehret, R., Polzer, U., Klostermann, F., Schwarz, J., et al. (2014) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000041 · Cited by 38
Antiparkinson Drug Use and Adherence in Medicare Part D Beneficiaries With Parkinson’s Disease
Wei, Y. J., Palumbo, F. B., Simoni, J. M., Shulman, L. M., Stuart, B., Beardsley, R. S., & Brown, C. H. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.09.001 · Cited by 38
Changes in Verbal Fluency in Parkinson's Disease
Rosenthal, L. S., Salnikova, Y., Pontone, G. M., Pantelyat, A. Y., Mills, K. A., Dorsey, E. R., Wang, J., Wu, S. S., & Mari, Z. K. (2016) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12421 · Cited by 37
Nonmotor Symptoms and Cognitive Decline in de novo Parkinson’s Disease
Kwon, K., Kang, S. H., Kim, M., Lee, H. M., Jang, J. W., Kim, J. Y., Lee, S.-M., & Koh, S. (2014) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2014.3 · Cited by 37
Adverse Events from the Treatment of Parkinson's Disease
Chou, K. L. (2008) · Neurologic Clinics · doi:10.1016/j.ncl.2008.05.003 · Cited by 37
Pezzoli, S., Cagnin, A., Antonini, A., & Venneri, A. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1656515 · Cited by 37
Factors contributing to institutionalization in patients with Huntington's disease
Rosenblatt, A., Kumar, B. V., Margolis, R. L., Welsh, C. S., & Ross, C. A. (2011) · Movement Disorders · doi:10.1002/mds.23716 · Cited by 40
SCOPA‐cognition cutoff value for detection of Parkinson's disease dementia
Verbaan, D., Jeukens‐Visser, M., van Laar, T., van Rooden, S. M., van Zwet, E. W., Marinus, J., & van Hilten, J. J. (2011) · Movement Disorders · doi:10.1002/mds.23750 · Cited by 37
Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease
Christopher, L., & Strafella, A. P. (2013) · Journal of Neuropsychology · doi:10.1111/jnp.12015 · Cited by 36
Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care
Taylor, J., Anderson, W. S., Brandt, J., Mari, Z. K., & Pontone, G. M. (2016) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2016.08.017 · Cited by 36
Interdisciplinary palliative care for people with advanced Parkinson’s disease: a view from the home
Fleisher, J. E., Klostermann, E. C., Hess, S., Lee, J., Myrick, E., & Chodosh, J. (2019) · Annals of Palliative Medicine · doi:10.21037/apm.2019.09.12 · Cited by 36
Cognitive correlates of visual hallucinations in non-demented Parkinson's disease patients
Hepp, D. H., da Hora, C. C., Koene, T., Uitdehaag, B. M. J., van den Heuvel, O. A., Klein, M., van de Berg, W. D. J., Berendse, H. W., & Foncke, E. M. J. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.04.026 · Cited by 36
Motor symptoms after deep brain stimulation of the subthalamic nucleus
Lilleeng, B., Gjerstad, M. D., Baardsen, R., Dalen, I., & Larsen, J. O. (2014) · Acta Neurologica Scandinavica · doi:10.1111/ane.12342 · Cited by 35
Self-citationParkinson Disease: Translating Insights from Molecular Mechanisms to Neuroprotection
Pirooznia, S. K., Rosenthal, L. S., Dawson, V. L., & Dawson, T. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000189 · Cited by 36
Characteristics of adult day care participants who enter a nursing home.
Cohen‐Mansfield, J., & Wirtz, P. W. (2007) · Psychology and Aging · doi:10.1037/0882-7974.22.2.354 · Cited by 36
Cognitive, Affective, and Psychiatric Features of Parkinson's Disease
Barbas, N. R. (2006) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2006.06.004 · Cited by 36
Wei, Y. J., Palumbo, F. B., Simoni, J. M., Shulman, L. M., Stuart, B., Beardsley, R. S., & Brown, C. H. (2014) · Value in Health · doi:10.1016/j.jval.2013.12.003 · Cited by 35
Association between family history of dementia and hallucinations in Parkinson disease
Paleacu, D., Schechtman, E., & Inzelberg, R. (2005) · Neurology · doi:10.1212/01.wnl.0000161872.85903.8e · Cited by 34
Antidepressants in the Treatment of Psychosis With Comorbid Depression in Parkinson Disease
Voon, V., & Lang, A. E. (2004) · Clinical Neuropharmacology · doi:10.1097/00002826-200403000-00009 · Cited by 34
Predictors of nursing home admission for older adults hospitalized with heart failure
Ahmed, A., Allman, R. M., & DeLong, J. F. (2003) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(02)00063-8 · Cited by 34
Lieto, J. M., & Schmidt, K. S. (2005) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2005.04.002 · Cited by 34
Zarkali, A., McColgan, P., Leyland, L. A., Lees, A. J., & Weil, R. S. (2022) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-326630 · Cited by 32
Armstrong, M., Tuijt, R., Read, J., Pigott, J., Davies, N., Manthorpe, J., Frost, R., Schrag, A. E., & Walters, K. R. (2021) · BMC Geriatrics · doi:10.1186/s12877-021-02678-w · Cited by 33
Continuous levodopa for advanced Parkinson’s disease
Lundqvist, C. (2007) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.a912 · Cited by 33
Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction
Ignatavicius, A., Matar, E., & Lewis, S. J. G. (2025) · Brain · doi:10.1093/brain/awae289 · Cited by 32
Zawiślak-Fornagiel, K., Ledwoń, D. J., Bugdol, M. N., Romaniszyn‐Kania, P., Małecki, A., Gorzkowska, A., & Mitas, A. W. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041569 · Cited by 30
Nonmotor symptom complex of Parkinson's disease--an under-recognized entity.
Mehndiratta, M., Garg, R., & Pandey, S. (2011) · PubMed · Cited by 32
Distinguishing Lewy body dementias from Alzheimer’s disease
Tarawneh, R. M., & Galvin, J. E. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.7.11.1499 · Cited by 32
Predictors of Discharges to a Nursing Home in a Hospital-Based Cohort
Smith, E. R., & Stevens, A. B. (2009) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2009.06.003 · Cited by 34
Narcolepsy in Parkinson’s disease
Haq, I. Z., Naidu, Y., Reddy, P., & Chaudhuri, К. R. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.56 · Cited by 32
Classic animal models of Parkinson’s disease: a historical perspective
Hamadjida, A., Frouni, I., Kwan, C., & Huot, P. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000441 · Cited by 32
A review of pramipexole and its clinical utility in Parkinson’s disease
Holloway, R. G., & Biglan, K. (2002) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.3.2.197 · Cited by 32
Parkinson's disease subtypes: Approaches and clinical implications
Deng, X., Mehta, A., Xiao, B., Chaudhuri, К. R., Tan, E., & Tan, L. C. (2024) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2024.107208 · Cited by 41
New tricks for old dogmas: Optogenetic and designer receptor insights for Parkinson's disease
Vazey, E. M., & Aston‐Jones, G. (2013) · Brain Research · doi:10.1016/j.brainres.2013.01.021 · Cited by 31
Kluger, B. M., Brown, R. P., Aerts, S. L., & Schenkman, M. L. (2014) · PM&R · doi:10.1016/j.pmrj.2014.05.013 · Cited by 31
Metadata
- Authors
- Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K.
- Affiliations
- Stavanger University Hospital (NO)
- Oslo University Hospital (NO)
- Corresponding author
- Aarsland, Dag
- ORCID
- Aarsland, Dag
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 48
- Issue
- 8
- Pages
- 938-942
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W2083220625
- Cited by
- 811
- References
- 21
- Citations by year
- 2026: 15 · 2025: 30 · 2024: 30 · 2023: 33 · 2022: 33 · 2021: 42 · 2020: 64 · 2019: 36 · 2018: 35 · 2017: 36 · 2016: 37 · 2015: 32 · 2014: 42 · 2013: 42 · 2012: 33
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Geriatrics Society (publishedVersion)
- PubMed (publishedVersion)
- Journal of the American Geriatrics Society
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Geriatrics and Gerontology › Geriatric Care and Nursing Homes
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Parkinson's disease, nursing home admission, institutionalization, predictors of institutionalization, hallucinations, dementia, functional disability, activities of daily living, motor symptoms, neuropsychiatric symptoms, depression, community-dwelling patients
- MeSH terms
- Activities of Daily Living, Adult, Aged, Aged, 80 and over, Dementia, Female, Hallucinations, Humans, Male, Middle Aged, Norway, Nursing Homes, Parkinson Disease, Patient Admission, Predictive Value of Tests, Prospective Studies, Psychiatric Status Rating Scales, Risk Factors, Severity of Illness Index, Geriatric Assessment, Linear Models, Proportional Hazards Models, Age Distribution, Community Health Planning
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
